Lumenis Expands Its Portfolio of Innovative Aesthetic Medical Solutions With Three New Product Introductions at the 72nd Annual Meeting of the American Academy of Dermatology

YOKNEAM, ISRAEL--(Marketwired - Mar 21, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world's largest medical laser company for aesthetic, surgical and ophthalmic applications, announced today the introduction of three new products that will be presented at the 72^nd Annual American Academy of Dermatology's (AAD) Meeting in Denver, Colorado from March 21 - 25 (booth #1336). The new products, which build on Lumenis' leadership in laser hair removal and skin rejuvenation, add to the most comprehensive portfolio of laser and energy-based technologies in dermatology. 

Among the highlights at the meeting, Lumenis will unveil LightSheer® INFINITY™ -- its most advanced laser hair removal workstation to-date -- and showcase the new LightSheer^® DESIRE™ system. Both LightSheer® INFINITY™ and LightSheer® DESIRE™ are up to 75 percent faster than other available devices and use Lumenis' proprietary HIT™ (High-Speed Integrated Technology) and ChillTip™ technologies for enhanced efficacy and patient comfort.

Lumenis will also introduce a new addition for the M22™ multi-application platform, the Q- Switched Nd:YAG module. The Q-Switched Nd:YAG module is designed for skin toning (by treatment of pigmented lesions), dark tattoo removal and can also be used for advanced combination treatments with the other M22™ modalities. This cost-effective upgrade to the M22™ platform features five spot sizes for versatility in applications and a top-hat, homogenous beam profile for optimal patient safety.

"As the medical aesthetic industry progresses, Lumenis is committed to advancing our legacy of five decades of innovative products that meet the needs of healthcare professionals and improve quality of life for patients," said Tzipi Ozer-Armon, CEO of Lumenis. "We look forward to partnering with the dermatology community to make these treatments available to patients across the globe."

Key Presentations Highlighting Lumenis Technologies at the 72^nd Annual AAD Meeting

Fractional Skin Resurfacing Symposium
Saturday, March 22, 2014, from 7:00 - 8:30 pm 
Denver Marriot City Center

The symposium will review current and future fractional skin resurfacing treatment strategies with leaders in the field, including R. Rox Anderson, M.D. and Dieter Manstein, M.D. of Harvard Medical School and E. Victor Ross, M.D. Visit Lumenis.com/AAD to register for the event. 

Featured Presentations at the Lumenis Exhibit Booth (#1336)

Saturday, March 22, 2014
Time		Presentation
12:00 - 12:45 pm		Utilizing Multiple Modes on the AcuPulse to Grow Your Cosmetic Practice Gilly Munavalli, M.D.
1:00 - 1:45 pm		Versatility of the M22: Pulsed Light, Q-Switched and Fractional Laser Treatment in One Platform Gilly Munavalli, M.D.
2:00 - 2:45 pm		Defeating Commoditization with Patient-Focused Care and Marketing Mitchel Goldman, M.D.
3:00 - 3:45 pm		3-Dimmensional Rejuvenation of the Aging Face with Injectables, Lasers and Light Sources Sabrini Fabi, M.D.
4:00 - 4:45 pm		How I Would Spend $100K on New Laser Technology Melanie Palm, M.D.
Sunday, March 23, 2014
Time		Presentation
12:00 - 12:45 pm		Providing Patients HOPE with Fractional Ablative Laser Therapy Nathan Uebelhoer, M.D.
1:00 - 1:45 pm		A World of Infinite Possibilities Vic Ross, M.D.
2:00 - 2:45 pm		A True Multipurpose System: M22 for Range of Patient Needs Mitchel Goldman, M.D.
3:00 - 3:45 pm		A New Standard for Treating Tattoo and Pigmentation Christine Lee, M.D.
4:00 - 4:45 pm		Introducing Photo-Fractional Therapy Melanie Palm, M.D.

LightSheer® INFINITY™ and LightSheer® DESIRE™ will also be featured at the 12th Anti-Aging Medicine World Congress, from April 3-5, 2014, in Monte Carlo, Monaco.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.

For more information visit: www.lumenis.com